Search results for the GEO ID: GSE11227 |
(Click on the check boxes provided under "Select for analysis", to initiate grouping) |
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down) |
|
GSM ID | GPL ID |
Select for analysis |
Title |
Source name |
Description |
Characteristics |
GSM283064 | GPL570 |
|
Patient before treatment-Replicate 1
|
Blood sample from patient before NHD treatment
|
RNA was extracted from whole blood before Nocturnal home hemodialysis (NHD)
|
RNA was extracted from whole blood before and after 2 months of established Nocturnal home hemodialysis
|
Sample_geo_accession | GSM283064
| Sample_status | Public on Dec 20 2008
| Sample_submission_date | Apr 21 2008
| Sample_last_update_date | Apr 21 2008
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_biomaterial_provider_ch1 | Our Nocturnal home hemodialysis patients at Toronto General Hospital
| Sample_treatment_protocol_ch1 | Medically stable Anemia secondary to end-stage renal disease patients (age between 18 – 85 years) who have received a minimum of 3 months of the conversion from conventional hemodialysis and were training for nocturnal home hemodialysis were invited to participate in this study
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Total RNA (TRNA) was isolated from blood samples utilizing Trizol Reagent (GIBCO/BRL) following the manufacturer's protocol. The quality of TRNA was assessed using the Agilent 2100 Bioanalyzer (version A.02.01S1232, Agilent Technologies). Only RNA with the OD ratio of 1.99-2.0 at 260/280 was used for microarray analysis.
| Sample_label_ch1 | Biotin
| Sample_label_protocol_ch1 | Affymetrix standard labeling protocol
| Sample_hyb_protocol | Affymetrix standard protocol
| Sample_scan_protocol | Affymetrix GeneChip Scanner 3000
| Sample_scan_protocol | Chips were examined for any defects and removed if any defect detected
| Sample_data_processing | Signals were scaled to 150
| Sample_platform_id | GPL570
| Sample_contact_name | Sara,,Arab
| Sample_contact_laboratory | John Coles
| Sample_contact_department | Cardiology
| Sample_contact_institute | Hospital for Sick Children
| Sample_contact_address | 555 University Ave
| Sample_contact_city | Toronto
| Sample_contact_state | ONT
| Sample_contact_zip/postal_code | M5G 1X8
| Sample_contact_country | Canada
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283064/suppl/GSM283064.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283064/suppl/GSM283064.CHP.gz
| Sample_series_id | GSE11227
| Sample_data_row_count | 54675
| |
|
GSM283065 | GPL570 |
|
Patient before treatment-Replicate 2
|
Blood sample from patient before NHD treatment
|
RNA was extracted from whole blood before Nocturnal home hemodialysis (NHD)
|
RNA was extracted from whole blood before and after 2 months of established Nocturnal home hemodialysis
|
Sample_geo_accession | GSM283065
| Sample_status | Public on Dec 20 2008
| Sample_submission_date | Apr 21 2008
| Sample_last_update_date | Apr 21 2008
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_biomaterial_provider_ch1 | Our Nocturnal home hemodialysis patients at Toronto General Hospital
| Sample_treatment_protocol_ch1 | Medically stable Anemia secondary to end-stage renal disease patients (age between 18 – 85 years) who have received a minimum of 3 months of the conversion from conventional hemodialysis and were training for nocturnal home hemodialysis were invited to participate in this study
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Total RNA (TRNA) was isolated from blood samples utilizing Trizol Reagent (GIBCO/BRL) following the manufacturer's protocol. The quality of TRNA was assessed using the Agilent 2100 Bioanalyzer (version A.02.01S1232, Agilent Technologies). Only RNA with the OD ratio of 1.99-2.0 at 260/280 was used for microarray analysis.
| Sample_label_ch1 | Biotin
| Sample_label_protocol_ch1 | Affymetrix standard labeling protocol
| Sample_hyb_protocol | Affymetrix standard protocol
| Sample_scan_protocol | Affymetrix GeneChip Scanner 3000
| Sample_scan_protocol | Chips were examined for any defects and removed if any defect detected
| Sample_data_processing | Signals were scaled to 150
| Sample_platform_id | GPL570
| Sample_contact_name | Sara,,Arab
| Sample_contact_laboratory | John Coles
| Sample_contact_department | Cardiology
| Sample_contact_institute | Hospital for Sick Children
| Sample_contact_address | 555 University Ave
| Sample_contact_city | Toronto
| Sample_contact_state | ONT
| Sample_contact_zip/postal_code | M5G 1X8
| Sample_contact_country | Canada
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283065/suppl/GSM283065.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283065/suppl/GSM283065.CHP.gz
| Sample_series_id | GSE11227
| Sample_data_row_count | 54675
| |
|
GSM283066 | GPL570 |
|
Patient before treatment-Replicate 3
|
Blood sample from patient before NHD treatment
|
RNA was extracted from whole blood before Nocturnal home hemodialysis (NHD)
|
RNA was extracted from whole blood before and after 2 months of established Nocturnal home hemodialysis
|
Sample_geo_accession | GSM283066
| Sample_status | Public on Dec 20 2008
| Sample_submission_date | Apr 21 2008
| Sample_last_update_date | Apr 21 2008
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_biomaterial_provider_ch1 | Our Nocturnal home hemodialysis patients at Toronto General Hospital
| Sample_treatment_protocol_ch1 | Medically stable Anemia secondary to end-stage renal disease patients (age between 18 – 85 years) who have received a minimum of 3 months of the conversion from conventional hemodialysis and were training for nocturnal home hemodialysis were invited to participate in this study
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Total RNA (TRNA) was isolated from blood samples utilizing Trizol Reagent (GIBCO/BRL) following the manufacturer's protocol. The quality of TRNA was assessed using the Agilent 2100 Bioanalyzer (version A.02.01S1232, Agilent Technologies). Only RNA with the OD ratio of 1.99-2.0 at 260/280 was used for microarray analysis.
| Sample_label_ch1 | Biotin
| Sample_label_protocol_ch1 | Affymetrix standard labeling protocol
| Sample_hyb_protocol | Affymetrix standard protocol
| Sample_scan_protocol | Affymetrix GeneChip Scanner 3000
| Sample_scan_protocol | Chips were examined for any defects and removed if any defect detected
| Sample_data_processing | Signals were scaled to 150
| Sample_platform_id | GPL570
| Sample_contact_name | Sara,,Arab
| Sample_contact_laboratory | John Coles
| Sample_contact_department | Cardiology
| Sample_contact_institute | Hospital for Sick Children
| Sample_contact_address | 555 University Ave
| Sample_contact_city | Toronto
| Sample_contact_state | ONT
| Sample_contact_zip/postal_code | M5G 1X8
| Sample_contact_country | Canada
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283066/suppl/GSM283066.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283066/suppl/GSM283066.CHP.gz
| Sample_series_id | GSE11227
| Sample_data_row_count | 54675
| |
|
GSM283067 | GPL570 |
|
Patient before treatment-Replicate 4
|
Blood sample from patient before NHD treatment
|
RNA was extracted from whole blood before Nocturnal home hemodialysis (NHD)
|
RNA was extracted from whole blood before and after 2 months of established Nocturnal home hemodialysis
|
Sample_geo_accession | GSM283067
| Sample_status | Public on Dec 20 2008
| Sample_submission_date | Apr 21 2008
| Sample_last_update_date | Apr 21 2008
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_biomaterial_provider_ch1 | Our Nocturnal home hemodialysis patients at Toronto General Hospital
| Sample_treatment_protocol_ch1 | Medically stable Anemia secondary to end-stage renal disease patients (age between 18 – 85 years) who have received a minimum of 3 months of the conversion from conventional hemodialysis and were training for nocturnal home hemodialysis were invited to participate in this study
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Total RNA (TRNA) was isolated from blood samples utilizing Trizol Reagent (GIBCO/BRL) following the manufacturer's protocol. The quality of TRNA was assessed using the Agilent 2100 Bioanalyzer (version A.02.01S1232, Agilent Technologies). Only RNA with the OD ratio of 1.99-2.0 at 260/280 was used for microarray analysis.
| Sample_label_ch1 | Biotin
| Sample_label_protocol_ch1 | Affymetrix standard labeling protocol
| Sample_hyb_protocol | Affymetrix standard protocol
| Sample_scan_protocol | Affymetrix GeneChip Scanner 3000
| Sample_scan_protocol | Chips were examined for any defects and removed if any defect detected
| Sample_data_processing | Signals were scaled to 150
| Sample_platform_id | GPL570
| Sample_contact_name | Sara,,Arab
| Sample_contact_laboratory | John Coles
| Sample_contact_department | Cardiology
| Sample_contact_institute | Hospital for Sick Children
| Sample_contact_address | 555 University Ave
| Sample_contact_city | Toronto
| Sample_contact_state | ONT
| Sample_contact_zip/postal_code | M5G 1X8
| Sample_contact_country | Canada
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283067/suppl/GSM283067.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283067/suppl/GSM283067.CHP.gz
| Sample_series_id | GSE11227
| Sample_data_row_count | 54675
| |
|
GSM283068 | GPL570 |
|
Patient before treatment-Replicate 5
|
Blood sample from patient before NHD treatment
|
RNA was extracted from whole blood before Nocturnal home hemodialysis (NHD)
|
RNA was extracted from whole blood before and after 2 months of established Nocturnal home hemodialysis
|
Sample_geo_accession | GSM283068
| Sample_status | Public on Dec 20 2008
| Sample_submission_date | Apr 21 2008
| Sample_last_update_date | Apr 21 2008
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_biomaterial_provider_ch1 | Our Nocturnal home hemodialysis patients at Toronto General Hospital
| Sample_treatment_protocol_ch1 | Medically stable Anemia secondary to end-stage renal disease patients (age between 18 – 85 years) who have received a minimum of 3 months of the conversion from conventional hemodialysis and were training for nocturnal home hemodialysis were invited to participate in this study
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Total RNA (TRNA) was isolated from blood samples utilizing Trizol Reagent (GIBCO/BRL) following the manufacturer's protocol. The quality of TRNA was assessed using the Agilent 2100 Bioanalyzer (version A.02.01S1232, Agilent Technologies). Only RNA with the OD ratio of 1.99-2.0 at 260/280 was used for microarray analysis.
| Sample_label_ch1 | Biotin
| Sample_label_protocol_ch1 | Affymetrix standard labeling protocol
| Sample_hyb_protocol | Affymetrix standard protocol
| Sample_scan_protocol | Affymetrix GeneChip Scanner 3000
| Sample_scan_protocol | Chips were examined for any defects and removed if any defect detected
| Sample_data_processing | Signals were scaled to 150
| Sample_platform_id | GPL570
| Sample_contact_name | Sara,,Arab
| Sample_contact_laboratory | John Coles
| Sample_contact_department | Cardiology
| Sample_contact_institute | Hospital for Sick Children
| Sample_contact_address | 555 University Ave
| Sample_contact_city | Toronto
| Sample_contact_state | ONT
| Sample_contact_zip/postal_code | M5G 1X8
| Sample_contact_country | Canada
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283068/suppl/GSM283068.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283068/suppl/GSM283068.CHP.gz
| Sample_series_id | GSE11227
| Sample_data_row_count | 54675
| |
|
GSM283069 | GPL570 |
|
Patient before treatment-Replicate 6
|
Blood sample from patient before NHD treatment
|
RNA was extracted from whole blood before Nocturnal home hemodialysis (NHD)
|
RNA was extracted from whole blood before and after 2 months of established Nocturnal home hemodialysis
|
Sample_geo_accession | GSM283069
| Sample_status | Public on Dec 20 2008
| Sample_submission_date | Apr 21 2008
| Sample_last_update_date | Apr 21 2008
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_biomaterial_provider_ch1 | Our Nocturnal home hemodialysis patients at Toronto General Hospital
| Sample_treatment_protocol_ch1 | Medically stable Anemia secondary to end-stage renal disease patients (age between 18 – 85 years) who have received a minimum of 3 months of the conversion from conventional hemodialysis and were training for nocturnal home hemodialysis were invited to participate in this study
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Total RNA (TRNA) was isolated from blood samples utilizing Trizol Reagent (GIBCO/BRL) following the manufacturer's protocol. The quality of TRNA was assessed using the Agilent 2100 Bioanalyzer (version A.02.01S1232, Agilent Technologies). Only RNA with the OD ratio of 1.99-2.0 at 260/280 was used for microarray analysis.
| Sample_label_ch1 | Biotin
| Sample_label_protocol_ch1 | Affymetrix standard labeling protocol
| Sample_hyb_protocol | Affymetrix standard protocol
| Sample_scan_protocol | Affymetrix GeneChip Scanner 3000
| Sample_scan_protocol | Chips were examined for any defects and removed if any defect detected
| Sample_data_processing | Signals were scaled to 150
| Sample_platform_id | GPL570
| Sample_contact_name | Sara,,Arab
| Sample_contact_laboratory | John Coles
| Sample_contact_department | Cardiology
| Sample_contact_institute | Hospital for Sick Children
| Sample_contact_address | 555 University Ave
| Sample_contact_city | Toronto
| Sample_contact_state | ONT
| Sample_contact_zip/postal_code | M5G 1X8
| Sample_contact_country | Canada
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283069/suppl/GSM283069.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283069/suppl/GSM283069.CHP.gz
| Sample_series_id | GSE11227
| Sample_data_row_count | 54675
| |
|
GSM283070 | GPL570 |
|
Patient before treatment-Replicate 7
|
Blood sample from patient before NHD treatment
|
RNA was extracted from whole blood before Nocturnal home hemodialysis (NHD)
|
RNA was extracted from whole blood before and after 2 months of established Nocturnal home hemodialysis
|
Sample_geo_accession | GSM283070
| Sample_status | Public on Dec 20 2008
| Sample_submission_date | Apr 21 2008
| Sample_last_update_date | Apr 21 2008
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_biomaterial_provider_ch1 | Our Nocturnal home hemodialysis patients at Toronto General Hospital
| Sample_treatment_protocol_ch1 | Medically stable Anemia secondary to end-stage renal disease patients (age between 18 – 85 years) who have received a minimum of 3 months of the conversion from conventional hemodialysis and were training for nocturnal home hemodialysis were invited to participate in this study
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Total RNA (TRNA) was isolated from blood samples utilizing Trizol Reagent (GIBCO/BRL) following the manufacturer's protocol. The quality of TRNA was assessed using the Agilent 2100 Bioanalyzer (version A.02.01S1232, Agilent Technologies). Only RNA with the OD ratio of 1.99-2.0 at 260/280 was used for microarray analysis.
| Sample_label_ch1 | Biotin
| Sample_label_protocol_ch1 | Affymetrix standard labeling protocol
| Sample_hyb_protocol | Affymetrix standard protocol
| Sample_scan_protocol | Affymetrix GeneChip Scanner 3000
| Sample_scan_protocol | Chips were examined for any defects and removed if any defect detected
| Sample_data_processing | Signals were scaled to 150
| Sample_platform_id | GPL570
| Sample_contact_name | Sara,,Arab
| Sample_contact_laboratory | John Coles
| Sample_contact_department | Cardiology
| Sample_contact_institute | Hospital for Sick Children
| Sample_contact_address | 555 University Ave
| Sample_contact_city | Toronto
| Sample_contact_state | ONT
| Sample_contact_zip/postal_code | M5G 1X8
| Sample_contact_country | Canada
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283070/suppl/GSM283070.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283070/suppl/GSM283070.CHP.gz
| Sample_series_id | GSE11227
| Sample_data_row_count | 54675
| |
|
GSM283071 | GPL570 |
|
Patient before treatment-Replicate 8
|
Blood sample from patient before NHD treatment
|
RNA was extracted from whole blood before Nocturnal home hemodialysis (NHD)
|
RNA was extracted from whole blood before and after 2 months of established Nocturnal home hemodialysis
|
Sample_geo_accession | GSM283071
| Sample_status | Public on Dec 20 2008
| Sample_submission_date | Apr 21 2008
| Sample_last_update_date | Apr 21 2008
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_biomaterial_provider_ch1 | Our Nocturnal home hemodialysis patients at Toronto General Hospital
| Sample_treatment_protocol_ch1 | Medically stable Anemia secondary to end-stage renal disease patients (age between 18 – 85 years) who have received a minimum of 3 months of the conversion from conventional hemodialysis and were training for nocturnal home hemodialysis were invited to participate in this study
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Total RNA (TRNA) was isolated from blood samples utilizing Trizol Reagent (GIBCO/BRL) following the manufacturer's protocol. The quality of TRNA was assessed using the Agilent 2100 Bioanalyzer (version A.02.01S1232, Agilent Technologies). Only RNA with the OD ratio of 1.99-2.0 at 260/280 was used for microarray analysis.
| Sample_label_ch1 | Biotin
| Sample_label_protocol_ch1 | Affymetrix standard labeling protocol
| Sample_hyb_protocol | Affymetrix standard protocol
| Sample_scan_protocol | Affymetrix GeneChip Scanner 3000
| Sample_scan_protocol | Chips were examined for any defects and removed if any defect detected
| Sample_data_processing | Signals were scaled to 150
| Sample_platform_id | GPL570
| Sample_contact_name | Sara,,Arab
| Sample_contact_laboratory | John Coles
| Sample_contact_department | Cardiology
| Sample_contact_institute | Hospital for Sick Children
| Sample_contact_address | 555 University Ave
| Sample_contact_city | Toronto
| Sample_contact_state | ONT
| Sample_contact_zip/postal_code | M5G 1X8
| Sample_contact_country | Canada
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283071/suppl/GSM283071.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283071/suppl/GSM283071.CHP.gz
| Sample_series_id | GSE11227
| Sample_data_row_count | 54675
| |
|
GSM283072 | GPL570 |
|
Patient after treatment-Replicate 1
|
Blood sample from patient after NHD treatment
|
RNA was extracted from whole blood after a minimum 3 months of Nocturnal home hemodialysis (NHD)
|
RNA was extracted from whole blood before and after 2 months of established Nocturnal home hemodialysis
|
Sample_geo_accession | GSM283072
| Sample_status | Public on Dec 20 2008
| Sample_submission_date | Apr 21 2008
| Sample_last_update_date | Apr 21 2008
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_biomaterial_provider_ch1 | Our Nocturnal home hemodialysis patients at Toronto General Hospital
| Sample_treatment_protocol_ch1 | Medically stable Anemia secondary to end-stage renal disease patients (age between 18 – 85 years) who have received a minimum of 3 months of the conversion from conventional hemodialysis and were training for nocturnal home hemodialysis were invited to participate in this study
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Total RNA (TRNA) was isolated from blood samples utilizing Trizol Reagent (GIBCO/BRL) following the manufacturer's protocol. The quality of TRNA was assessed using the Agilent 2100 Bioanalyzer (version A.02.01S1232, Agilent Technologies). Only RNA with the OD ratio of 1.99-2.0 at 260/280 was used for microarray analysis.
| Sample_label_ch1 | Biotin
| Sample_label_protocol_ch1 | Affymetrix standard labeling protocol
| Sample_hyb_protocol | Affymetrix standard protocol
| Sample_scan_protocol | Affymetrix GeneChip Scanner 3000
| Sample_scan_protocol | Chips were examined for any defects and removed if any defect detected
| Sample_data_processing | Signals were scaled to 150
| Sample_platform_id | GPL570
| Sample_contact_name | Sara,,Arab
| Sample_contact_laboratory | John Coles
| Sample_contact_department | Cardiology
| Sample_contact_institute | Hospital for Sick Children
| Sample_contact_address | 555 University Ave
| Sample_contact_city | Toronto
| Sample_contact_state | ONT
| Sample_contact_zip/postal_code | M5G 1X8
| Sample_contact_country | Canada
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283072/suppl/GSM283072.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283072/suppl/GSM283072.CHP.gz
| Sample_series_id | GSE11227
| Sample_data_row_count | 54675
| |
|
GSM283073 | GPL570 |
|
Patient after treatment-Replicate 2
|
Blood sample from patient after NHD treatment
|
RNA was extracted from whole blood after a minimum 3 months of Nocturnal home hemodialysis (NHD)
|
RNA was extracted from whole blood before and after a minimum 3 months of established Nocturnal home hemodialysis
|
Sample_geo_accession | GSM283073
| Sample_status | Public on Dec 20 2008
| Sample_submission_date | Apr 21 2008
| Sample_last_update_date | Apr 21 2008
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_biomaterial_provider_ch1 | Our Nocturnal home hemodialysis patients at Toronto General Hospital
| Sample_treatment_protocol_ch1 | Medically stable Anemia secondary to end-stage renal disease patients (age between 18 – 85 years) who have received a minimum of 3 months of the conversion from conventional hemodialysis and were training for nocturnal home hemodialysis were invited to participate in this study
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Total RNA (TRNA) was isolated from blood samples utilizing Trizol Reagent (GIBCO/BRL) following the manufacturer's protocol. The quality of TRNA was assessed using the Agilent 2100 Bioanalyzer (version A.02.01S1232, Agilent Technologies). Only RNA with the OD ratio of 1.99-2.0 at 260/280 was used for microarray analysis.
| Sample_label_ch1 | Biotin
| Sample_label_protocol_ch1 | Affymetrix standard labeling protocol
| Sample_hyb_protocol | Affymetrix standard protocol
| Sample_scan_protocol | Affymetrix GeneChip Scanner 3000
| Sample_scan_protocol | Chips were examined for any defects and removed if any defect detected
| Sample_data_processing | Signals were scaled to 150
| Sample_platform_id | GPL570
| Sample_contact_name | Sara,,Arab
| Sample_contact_laboratory | John Coles
| Sample_contact_department | Cardiology
| Sample_contact_institute | Hospital for Sick Children
| Sample_contact_address | 555 University Ave
| Sample_contact_city | Toronto
| Sample_contact_state | ONT
| Sample_contact_zip/postal_code | M5G 1X8
| Sample_contact_country | Canada
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283073/suppl/GSM283073.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283073/suppl/GSM283073.CHP.gz
| Sample_series_id | GSE11227
| Sample_data_row_count | 54675
| |
|
GSM283074 | GPL570 |
|
Patient after treatment-Replicate 3
|
Blood sample from patient after NHD treatment
|
RNA was extracted from whole blood after a minimum 3 months of Nocturnal home hemodialysis (NHD)
|
RNA was extracted from whole blood before and after a minimum 3 months of established Nocturnal home hemodialysis
|
Sample_geo_accession | GSM283074
| Sample_status | Public on Dec 20 2008
| Sample_submission_date | Apr 21 2008
| Sample_last_update_date | Apr 21 2008
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_biomaterial_provider_ch1 | Our Nocturnal home hemodialysis patients at Toronto General Hospital
| Sample_treatment_protocol_ch1 | Medically stable Anemia secondary to end-stage renal disease patients (age between 18 – 85 years) who have received a minimum of 3 months of the conversion from conventional hemodialysis and were training for nocturnal home hemodialysis were invited to participate in this study
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Total RNA (TRNA) was isolated from blood samples utilizing Trizol Reagent (GIBCO/BRL) following the manufacturer's protocol. The quality of TRNA was assessed using the Agilent 2100 Bioanalyzer (version A.02.01S1232, Agilent Technologies). Only RNA with the OD ratio of 1.99-2.0 at 260/280 was used for microarray analysis.
| Sample_label_ch1 | Biotin
| Sample_label_protocol_ch1 | Affymetrix standard labeling protocol
| Sample_hyb_protocol | Affymetrix standard protocol
| Sample_scan_protocol | Affymetrix GeneChip Scanner 3000
| Sample_scan_protocol | Chips were examined for any defects and removed if any defect detected
| Sample_data_processing | Signals were scaled to 150
| Sample_platform_id | GPL570
| Sample_contact_name | Sara,,Arab
| Sample_contact_laboratory | John Coles
| Sample_contact_department | Cardiology
| Sample_contact_institute | Hospital for Sick Children
| Sample_contact_address | 555 University Ave
| Sample_contact_city | Toronto
| Sample_contact_state | ONT
| Sample_contact_zip/postal_code | M5G 1X8
| Sample_contact_country | Canada
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283074/suppl/GSM283074.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283074/suppl/GSM283074.CHP.gz
| Sample_series_id | GSE11227
| Sample_data_row_count | 54675
| |
|
GSM283075 | GPL570 |
|
Patient after treatment-Replicate 4
|
Blood sample from patient after NHD treatment
|
RNA was extracted from whole blood after a minimum 3 months of Nocturnal home hemodialysis (NHD)
|
RNA was extracted from whole blood before and after a minimum 3 months of established Nocturnal home hemodialysis
|
Sample_geo_accession | GSM283075
| Sample_status | Public on Dec 20 2008
| Sample_submission_date | Apr 21 2008
| Sample_last_update_date | Apr 21 2008
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_biomaterial_provider_ch1 | Our Nocturnal home hemodialysis patients at Toronto General Hospital
| Sample_treatment_protocol_ch1 | Medically stable Anemia secondary to end-stage renal disease patients (age between 18 – 85 years) who have received a minimum of 3 months of the conversion from conventional hemodialysis and were training for nocturnal home hemodialysis were invited to participate in this study
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Total RNA (TRNA) was isolated from blood samples utilizing Trizol Reagent (GIBCO/BRL) following the manufacturer's protocol. The quality of TRNA was assessed using the Agilent 2100 Bioanalyzer (version A.02.01S1232, Agilent Technologies). Only RNA with the OD ratio of 1.99-2.0 at 260/280 was used for microarray analysis.
| Sample_label_ch1 | Biotin
| Sample_label_protocol_ch1 | Affymetrix standard labeling protocol
| Sample_hyb_protocol | Affymetrix standard protocol
| Sample_scan_protocol | Affymetrix GeneChip Scanner 3000
| Sample_scan_protocol | Chips were examined for any defects and removed if any defect detected
| Sample_data_processing | Signals were scaled to 150
| Sample_platform_id | GPL570
| Sample_contact_name | Sara,,Arab
| Sample_contact_laboratory | John Coles
| Sample_contact_department | Cardiology
| Sample_contact_institute | Hospital for Sick Children
| Sample_contact_address | 555 University Ave
| Sample_contact_city | Toronto
| Sample_contact_state | ONT
| Sample_contact_zip/postal_code | M5G 1X8
| Sample_contact_country | Canada
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283075/suppl/GSM283075.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283075/suppl/GSM283075.CHP.gz
| Sample_series_id | GSE11227
| Sample_data_row_count | 54675
| |
|
GSM283076 | GPL570 |
|
Patient after treatment-Replicate 5
|
Blood sample from patient after NHD treatment
|
RNA was extracted from whole blood after a minimum 3 months of Nocturnal home hemodialysis (NHD)
|
RNA was extracted from whole blood before and after a minimum 3 months of established Nocturnal home hemodialysis
|
Sample_geo_accession | GSM283076
| Sample_status | Public on Dec 20 2008
| Sample_submission_date | Apr 21 2008
| Sample_last_update_date | Apr 21 2008
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_biomaterial_provider_ch1 | Our Nocturnal home hemodialysis patients at Toronto General Hospital
| Sample_treatment_protocol_ch1 | Medically stable Anemia secondary to end-stage renal disease patients (age between 18 – 85 years) who have received a minimum of 3 months of the conversion from conventional hemodialysis and were training for nocturnal home hemodialysis were invited to participate in this study
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Total RNA (TRNA) was isolated from blood samples utilizing Trizol Reagent (GIBCO/BRL) following the manufacturer's protocol. The quality of TRNA was assessed using the Agilent 2100 Bioanalyzer (version A.02.01S1232, Agilent Technologies). Only RNA with the OD ratio of 1.99-2.0 at 260/280 was used for microarray analysis.
| Sample_label_ch1 | Biotin
| Sample_label_protocol_ch1 | Affymetrix standard labeling protocol
| Sample_hyb_protocol | Affymetrix standard protocol
| Sample_scan_protocol | Affymetrix GeneChip Scanner 3000
| Sample_scan_protocol | Chips were examined for any defects and removed if any defect detected
| Sample_data_processing | Signals were scaled to 150
| Sample_platform_id | GPL570
| Sample_contact_name | Sara,,Arab
| Sample_contact_laboratory | John Coles
| Sample_contact_department | Cardiology
| Sample_contact_institute | Hospital for Sick Children
| Sample_contact_address | 555 University Ave
| Sample_contact_city | Toronto
| Sample_contact_state | ONT
| Sample_contact_zip/postal_code | M5G 1X8
| Sample_contact_country | Canada
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283076/suppl/GSM283076.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283076/suppl/GSM283076.CHP.gz
| Sample_series_id | GSE11227
| Sample_data_row_count | 54675
| |
|
GSM283077 | GPL570 |
|
Patient after treatment-Replicate 6
|
Blood sample from patient after NHD treatment
|
RNA was extracted from whole blood after a minimum 3 months of Nocturnal home hemodialysis (NHD)
|
RNA was extracted from whole blood before and after a minimum 3 months of established Nocturnal home hemodialysis
|
Sample_geo_accession | GSM283077
| Sample_status | Public on Dec 20 2008
| Sample_submission_date | Apr 21 2008
| Sample_last_update_date | Apr 21 2008
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_biomaterial_provider_ch1 | Our Nocturnal home hemodialysis patients at Toronto General Hospital
| Sample_treatment_protocol_ch1 | Medically stable Anemia secondary to end-stage renal disease patients (age between 18 – 85 years) who have received a minimum of 3 months of the conversion from conventional hemodialysis and were training for nocturnal home hemodialysis were invited to participate in this study
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Total RNA (TRNA) was isolated from blood samples utilizing Trizol Reagent (GIBCO/BRL) following the manufacturer's protocol. The quality of TRNA was assessed using the Agilent 2100 Bioanalyzer (version A.02.01S1232, Agilent Technologies). Only RNA with the OD ratio of 1.99-2.0 at 260/280 was used for microarray analysis.
| Sample_label_ch1 | Biotin
| Sample_label_protocol_ch1 | Affymetrix standard labeling protocol
| Sample_hyb_protocol | Affymetrix standard protocol
| Sample_scan_protocol | Affymetrix GeneChip Scanner 3000
| Sample_scan_protocol | Chips were examined for any defects and removed if any defect detected
| Sample_data_processing | Signals were scaled to 150
| Sample_platform_id | GPL570
| Sample_contact_name | Sara,,Arab
| Sample_contact_laboratory | John Coles
| Sample_contact_department | Cardiology
| Sample_contact_institute | Hospital for Sick Children
| Sample_contact_address | 555 University Ave
| Sample_contact_city | Toronto
| Sample_contact_state | ONT
| Sample_contact_zip/postal_code | M5G 1X8
| Sample_contact_country | Canada
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283077/suppl/GSM283077.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283077/suppl/GSM283077.CHP.gz
| Sample_series_id | GSE11227
| Sample_data_row_count | 54675
| |
|
GSM283078 | GPL570 |
|
Patient after treatment-Replicate 7
|
Blood sample from patient after NHD treatment
|
RNA was extracted from whole blood after a minimum 3 months of Nocturnal home hemodialysis (NHD)
|
RNA was extracted from whole blood before and after a minimum 3 months of established Nocturnal home hemodialysis
|
Sample_geo_accession | GSM283078
| Sample_status | Public on Dec 20 2008
| Sample_submission_date | Apr 21 2008
| Sample_last_update_date | Apr 21 2008
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_biomaterial_provider_ch1 | Our Nocturnal home hemodialysis patients at Toronto General Hospital
| Sample_treatment_protocol_ch1 | Medically stable Anemia secondary to end-stage renal disease patients (age between 18 – 85 years) who have received a minimum of 3 months of the conversion from conventional hemodialysis and were training for nocturnal home hemodialysis were invited to participate in this study
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Total RNA (TRNA) was isolated from blood samples utilizing Trizol Reagent (GIBCO/BRL) following the manufacturer's protocol. The quality of TRNA was assessed using the Agilent 2100 Bioanalyzer (version A.02.01S1232, Agilent Technologies). Only RNA with the OD ratio of 1.99-2.0 at 260/280 was used for microarray analysis.
| Sample_label_ch1 | Biotin
| Sample_label_protocol_ch1 | Affymetrix standard labeling protocol
| Sample_hyb_protocol | Affymetrix standard protocol
| Sample_scan_protocol | Affymetrix GeneChip Scanner 3000
| Sample_scan_protocol | Chips were examined for any defects and removed if any defect detected
| Sample_data_processing | Signals were scaled to 150
| Sample_platform_id | GPL570
| Sample_contact_name | Sara,,Arab
| Sample_contact_laboratory | John Coles
| Sample_contact_department | Cardiology
| Sample_contact_institute | Hospital for Sick Children
| Sample_contact_address | 555 University Ave
| Sample_contact_city | Toronto
| Sample_contact_state | ONT
| Sample_contact_zip/postal_code | M5G 1X8
| Sample_contact_country | Canada
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283078/suppl/GSM283078.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283078/suppl/GSM283078.CHP.gz
| Sample_series_id | GSE11227
| Sample_data_row_count | 54675
| |
|
GSM283079 | GPL570 |
|
Patient after treatment-Replicate 8
|
Blood sample from patient after NHD treatment
|
RNA was extracted from whole blood after a minimum 3 months of Nocturnal home hemodialysis (NHD)
|
RNA was extracted from whole blood before and after a minimum 3 months of established Nocturnal home hemodialysis
|
Sample_geo_accession | GSM283079
| Sample_status | Public on Dec 20 2008
| Sample_submission_date | Apr 21 2008
| Sample_last_update_date | Apr 21 2008
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_biomaterial_provider_ch1 | Our Nocturnal home hemodialysis patients at Toronto General Hospital
| Sample_treatment_protocol_ch1 | Medically stable Anemia secondary to end-stage renal disease patients (age between 18 – 85 years) who have received a minimum of 3 months of the conversion from conventional hemodialysis and were training for nocturnal home hemodialysis were invited to participate in this study
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Total RNA (TRNA) was isolated from blood samples utilizing Trizol Reagent (GIBCO/BRL) following the manufacturer's protocol. The quality of TRNA was assessed using the Agilent 2100 Bioanalyzer (version A.02.01S1232, Agilent Technologies). Only RNA with the OD ratio of 1.99-2.0 at 260/280 was used for microarray analysis.
| Sample_label_ch1 | Biotin
| Sample_label_protocol_ch1 | Affymetrix standard labeling protocol
| Sample_hyb_protocol | Affymetrix standard protocol
| Sample_scan_protocol | Affymetrix GeneChip Scanner 3000
| Sample_scan_protocol | Chips were examined for any defects and removed if any defect detected
| Sample_data_processing | Signals were scaled to 150
| Sample_platform_id | GPL570
| Sample_contact_name | Sara,,Arab
| Sample_contact_laboratory | John Coles
| Sample_contact_department | Cardiology
| Sample_contact_institute | Hospital for Sick Children
| Sample_contact_address | 555 University Ave
| Sample_contact_city | Toronto
| Sample_contact_state | ONT
| Sample_contact_zip/postal_code | M5G 1X8
| Sample_contact_country | Canada
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283079/suppl/GSM283079.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM283nnn/GSM283079/suppl/GSM283079.CHP.gz
| Sample_series_id | GSE11227
| Sample_data_row_count | 54675
| |
|
|
|
Make groups for comparisons |
(2 groups will be compared at a time) |
|
Select GSMs and click on "Add groups" |
Enter the group name here: |
|
|
|